Literature DB >> 8012755

Epstein-Barr virus: adaptation to a life within the immune system.

M G Masucci1, I Ernberg.   

Abstract

Epstein-Barr virus has developed multiple strategies to ensure its long-term persistence in the infected B cells of immunocompetent hosts. These include the establishment of cell-phenotype-specific programs of viral gene expression and the transduction of cellular genes that modulate immune responses. Cytotoxic T cells may specifically influence the evolution of this genetically stable virus.

Entities:  

Mesh：

Year:  1994        PMID： 8012755     DOI： 10.1016/0966-842x(94)90599-1

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  33 in total

1.  Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.

Authors:  A M Joseph; G J Babcock; D A Thorley-Lawson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Authors:  P Steigerwald-Mullen; M G Kurilla; T J Braciale
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Authors:  Donna Hochberg; Jaap M Middeldorp; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

4.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Authors:  J Levitskaya; A Sharipo; A Leonchiks; A Ciechanover; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.

Authors:  E M Fuentes-Pananá; P D Ling
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.

Authors:  L L Decker; L D Klaman; D A Thorley-Lawson
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 7.  The complexity of the Epstein-Barr virus infection in humans.

Authors:  E Klein
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.

Authors:  E M Miyashita; B Yang; G J Babcock; D A Thorley-Lawson
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.

Authors:  Akira Satou; Tetsuya Tabata; Yuka Suzuki; Yasuharu Sato; Ippei Tahara; Kunio Mochizuki; Naoki Oishi; Taishi Takahara; Tadashi Yoshino; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Virchows Arch       Date:  2020-11-09       Impact factor: 4.064

10.  Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.

Authors:  I K Ruf; A Moghaddam; F Wang; J Sample
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.